CVE-2025-0417

CVE-2025-0417 is a high-severity vulnerability with a CVSS 4.0 base score of 7.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-307.

Key facts

Description

Lack of protection against brute force attacks in Valmet DNA visualization in DNA Operate. The possibility to make an arbitrary number of login attempts without any rate limit gives an attacker an increased chance of guessing passwords and then performing switching operations.

Frequently asked questions

What is CVE-2025-0417?
Lack of protection against brute force attacks in Valmet DNA visualization in DNA Operate. The possibility to make an arbitrary number of login attempts without any rate limit gives an attacker an increased chance of guessing passwords and then performing switching operations.
How severe is CVE-2025-0417?
CVE-2025-0417 has a CVSS 4.0 base score of 7.0, rated high severity.
Is CVE-2025-0417 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (5th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-0417?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-0417 have an EU (EUVD) identifier?
Yes. CVE-2025-0417 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-9116.
When was CVE-2025-0417 published?
CVE-2025-0417 was published on 2025-04-01 and last updated on 2026-06-17.

References

Other CWE-307 (Improper Restriction of Excessive Authentication Attempts) vulnerabilities

Browse all CWE-307 (Improper Restriction of Excessive Authentication Attempts) vulnerabilities →